MedPath

MERZ NORTH AMERICA, INC.

MERZ NORTH AMERICA, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1908-01-01
Employees
501
Market Cap
-
Website
http://www.merzusa.com

Clinical Trials

48

Active:0
Completed:43

Trial Phases

5 Phases

Phase 1:1
Phase 2:1
Phase 3:11
+2 more phases

Drug Approvals

1

FDA:1

Drug Approvals

Xeomin

Approval Date
Sep 14, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
25 (55.6%)
Phase 3
11 (24.4%)
Phase 4
7 (15.6%)
Phase 1
1 (2.2%)
Phase 2
1 (2.2%)

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Not Applicable
Completed
Conditions
Injection Site Reaction
First Posted Date
2023-10-23
Last Posted Date
2024-12-13
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
20
Registration Number
NCT06093815
Locations
🇪🇸

Ocean Clinic - Av. Ramon y Cajal 7, 29601, Marbella, Spain

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

Phase 1
Completed
Conditions
Enlarged Pores
Sebum Production
Interventions
Drug: Placebo
First Posted Date
2023-03-24
Last Posted Date
2024-08-23
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
31
Registration Number
NCT05784363
Locations
🇺🇸

Merz Investigation Site #0010473, Los Angeles, California, United States

🇺🇸

Merz Investigation Site #0010101, Coral Gables, Florida, United States

🇺🇸

Merz Investigation Site #001097, Nashville, Tennessee, United States

Longitudinal Evaluation and Real-world Evidence of NT201

Terminated
Conditions
Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face
Interventions
First Posted Date
2022-02-03
Last Posted Date
2023-06-07
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
11
Registration Number
NCT05222607
Locations
🇺🇸

SkinDC, Arlington, Virginia, United States

Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles

Not Applicable
Completed
Conditions
Décolleté Wrinkles
First Posted Date
2021-12-20
Last Posted Date
2025-07-02
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
152
Registration Number
NCT05163353
Locations
🇺🇸

Clinical Testing of Beverly Hills, Merz Investigational Site #0010395, Beverly Hills, California, United States

🇺🇸

Facial Plastic Surgery, Merz Investigational Site #0010463, Redondo Beach, California, United States

🇺🇸

Cosmetic Laser Dermatology, Merz Investigational Site #0010321, San Diego, California, United States

and more 6 locations

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

Not Applicable
Completed
Conditions
Cheek Volume Augmentation
First Posted Date
2021-05-14
Last Posted Date
2023-05-24
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
202
Registration Number
NCT04886232
Locations
🇩🇪

Hautmedizin Bad Soden, Merz Investigational Site #0490189, Bad Soden am Taunus, Germany

🇩🇪

Rosenparkklinik, Merz Investigational Site #0490099, Darmstadt, Germany

🇩🇪

Praxis für Hautkrankheiten, Merz Investigational Site #0490375, Drensteinfurt, Germany

and more 7 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.